COST$909.01+0.71%PEP$137.63+0.69%NFLX$75.65-0.49%ADBE$250.15-1.85%CSCO$108.64-0.72%PANW$329.02-1.81%CRWD$203.99-1.83%PLTR$166.20-1.96%ABNB$168.16-0.87%BKNG$172.00-0.82%HON$204.84-0.04%LIN$466.09-0.12%ISRG$351.66-0.45%AMGN$389.78-0.38%GILD$146.59+0.65%INTU$311.55-0.76%COST$909.01+0.71%PEP$137.63+0.69%NFLX$75.65-0.49%ADBE$250.15-1.85%CSCO$108.64-0.72%PANW$329.02-1.81%CRWD$203.99-1.83%PLTR$166.20-1.96%ABNB$168.16-0.87%BKNG$172.00-0.82%HON$204.84-0.04%LIN$466.09-0.12%ISRG$351.66-0.45%AMGN$389.78-0.38%GILD$146.59+0.65%INTU$311.55-0.76%
Gilead Sciences (GILD)
NASDAQ · USD
$146.59+0.65% ($0.94)
Market closed · Last known quote: Sep 10, 2026, 6:26 PM GMT+0530
Previous Close$145.65
Open$113.19
Day's Range$112.29 - $113.57
52 Week Range$108.46 - $157.29
Volume3.19K
Avg. Volume5.00M
Market Cap$181.77B
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)N/A
Forward Dividend & YieldN/A
1y Target EstN/A
People also watch
Intel CorporationINTC$101.94-4.05%
Micron TechnologyMU$997.09-2.99%
Advanced Micro DevicesAMD$507.41-2.63%
QUALCOMMQCOM$172.68-2.11%
AdobeADBE$250.15-1.85%
Exxon MobilXOM$167.24+1.83%
Broadcom Inc.AVGO$357.80-1.81%
ChevronCVX$217.33+1.65%
OracleORCL$159.10-1.57%
NVIDIANVDA$220.40-1.35%
IBMIBM$236.70-1.35%
Johnson & JohnsonJNJ$270.50+1.28%
Coca-ColaKO$88.43+1.01%
UnitedHealth GroupUNH$396.86+0.97%
WalmartWMT$106.65+0.77%
Procter & GamblePG$143.70+0.74%
Related in Drug Manufacturers—General
AmgenAMGN$389.78-0.38%
Intuitive SurgicalISRG$351.66-0.45%
Johnson & JohnsonJNJ$270.50+1.28%
Eli LillyLLY$1,130.40+0.55%
AbbVieABBV$251.92+0.40%
MerckMRK$147.60+0.05%
PfizerPFE$27.84+0.22%
AstraZenecaAZN.L£11,578-0.62%
SanofiSAN€98.60+1.19%
NovartisNOVNCHF 108.60-2.15%
RocheROGCHF 278.40-0.23%
NovartisNOVN.SWCHF 108.60-2.15%
About Gilead Sciences
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.…
From the companyLearn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Financial statistics
Valuation Measures
| Market Cap | $181.77B |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio | N/A |
| Price/Sales | N/A |
| Price/Book | N/A |
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 5.00M |
| Shares Outstanding | 1.25B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Technical analysis
Summary
Sell
Last price is below the short and medium moving averages. RSI 0.1, MACD negative. Trend: downtrend.
TrendDowntrend
RSI (14)0.1
MACD-0.084
SMA 20$113.33
SMA 50$113.40
SMA 200$113.42
Support$112.60
Resistance$113.46
Stochastic %K4.3
ATR (14)0.099
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Sell | Medium-term trend is down. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Buy | RSI is oversold below 30. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Buy | Stochastic %K is oversold. |
Company profile
SectorHealthcare
IndustryDrug Manufacturers—General
Employees18,000
CEODaniel O'Day
HeadquartersFoster City
CountryUnited States
FoundedJun 1987
Legal formDelaware corporation
ChairpersonDaniel O'Day
OrganisationAmerican biopharmaceutical company
Website
www.gilead.com
Key management
- Daniel O'Day Chief Executive Officer
Historical price data
Currency in USD| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Loading recent price history | |||||
News & official updates
Price quotes and the 1D chart refresh every few seconds while this page stays open — no reload needed. Last trade is taken from the exchange feed where available; some venues delay 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.